After-Hours Movers 3/3: QSC, OVEN Up on Earnings, BRL Higher on Patent Issue; OMPI, SLXP, BKS Sink on Earnings
Questcor Pharmaceuticals, Inc. (AMEX: QSC) 17.3% HIGHER; reports Q4 EPS of $0.45 compared to a $0.06 loss for the same period last year. Revenues were $27.1 million for Q4 compared to $3.4 million for the same period last year. Separately, the QSC board approves the repurchase plan for up to 7 million shares.
Obagi Medical Products, Inc. (NASDAQ: OMPI) 12% LOWER; reports Q4 EPS of $0.21, cents better than the analyst estimate of $0.. Revenues for the quarter were $27.3 million, versus the consensus of $ million. Sees FY08 EPS in the range of $0.94-$0.98 and sales of $120-$125 million. The Street estimates are $0.98 and $127.65 million, respectively.
TurboChef Technologies, Inc. (NASDAQ: OVEN) 8.6% HIGHER; reports a Q4 loss of $0.14 vs. consensus of $0.03 profit - may not be comparable. Revenues were $34.3 million vs. $33.48 million consensus.
Subscribe to EasyStockAlerts and get real-time e-mail alerts when news hits your stocks!
Salix Pharmaceuticals, Inc (Nasdaq: SLXP) 8.4% LOWER; reports a Q4 loss of $0.40, which may not compare to the analyst estimate of $0.30. Revenues for the quarter were $71.554 million, versus the consensus of $67.77 million
Barr Pharmaceuticals, Inc. (NYSE: BRL) 7.3% HIGHER; announced that the U.S. District Court for the District of New Jersey has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Bayer Schering Pharma, AG in connection with Bayer Schering's Yasmin (drospirenone and ethinyl estradiol) oral contraceptive.
F.N.B. Corp. (NYSE: FNB) 7% HIGHER; is surging after-hours on above average volume despite no news.
Barnes & Noble (NYSE: BKS) 4.7% LOWER; reports Q4 revenues of $1.51 billion, versus the consensus of $1.84 billion. Same store sales fell 0.5% during the quarter. Sees Q4 EPS, excluding items, of $1.57-$1.76. The Street estimate is $1.71. FY08 EPS are expected to be in the range of $1.70-$1.90, versus the consensus of $1.88.
Related Categories
Special ReportsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
